Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial

Transfusion. 2017 Oct;57(10):2532-2538. doi: 10.1111/trf.14193. Epub 2017 Jul 3.
No abstract available

MeSH terms

  • ADAMTS13 Protein / blood
  • ADAMTS13 Protein / deficiency
  • Adolescent
  • Adult
  • Aged
  • Clinical Protocols
  • Data Collection
  • Diagnostic Errors
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multicenter Studies as Topic* / methods
  • National Heart, Lung, and Blood Institute (U.S.)
  • Patient Selection*
  • Purpura, Thrombotic Thrombocytopenic / blood
  • Purpura, Thrombotic Thrombocytopenic / diagnosis
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Randomized Controlled Trials as Topic* / methods
  • Research Design
  • Rituximab / therapeutic use*
  • Treatment Outcome
  • United States
  • Young Adult

Substances

  • Rituximab
  • ADAMTS13 Protein
  • ADAMTS13 protein, human